Efficacy of Nifedipine in Preterm Labor for Prolongation of Pregnancy for at Least 48 Hours
DOI:
https://doi.org/10.70749/ijbr.v3i5.1191Keywords:
Nifedipine, Preterm Labor, Tocolysis, Pregnancy Prolongation, Neonatal OutcomesAbstract
Introduction: The occurrence of preterm labor during the first 37 weeks of pregnancy creates substantial risks to newborns, which requires effective tocolytic treatments. The calcium channel-blocking drug Nifedipine serves as a common medication for pregnancy delay to enable corticosteroid administration as well as maternal transfer to advanced care centers (1). Objective: This study determines how nifedipine affects maternal-neonatal outcomes while measuring its ability to extend pregnancy more than 48 hours in women experiencing preterm labor. Materials and Method: The study was conducted from 1st August, 2024 to 31st January, 2025 in Unit 2 of Services Hospital, Lahore and accepted 78 women from 15 to 40 years' old who were carrying single baby fetuses between 28–34 weeks + 5 days. The patients received nifedipine by mouth, starting with 20 mg as a loading dose, followed by up to 160 mg daily over 48 to 72 hours. Data were analyzed using SPSS 20.0 (p<0.05). Results: The duration of Nifedipine treatment Treated 64 women during labor for more than 48 hours (82.1%), but age, gestational age, and parity did not create any essential differences (p>0.05).
References
Aslam, Z., Majeed, K., Maryam, W. and Sajjad, A., 2025. EFFICACY AND SAFETY OF NIFEDIPINE IN SUPPRESSION OF PRETERM LABOR. The Research of Medical Science Review, 3(2), pp.327-332.
Nasrolahei, S., Hoseini, S.A., Hosseini, S.A., Hosseini, S.N.K., Hosseini, S.S. and Lotfi, P.M., 2023. Effect of nifedipine with and without sildenafil citrate for the management of preterm labor in pregnant women: A randomized clinical trial. International Journal of Reproductive BioMedicine, 21(5), p.379.
https://doi.org/10.18502/ijrm.v21i5.13471
Dağdeviren, G., Aksoy, M., Çelik, Ö.Y., Keleş, A., Çelen, Ş. and Çağlar, A.T., 2022. Nifedipine and indomethacin in preventing preterm labor under 32 gestational weeks.
https://doi.org/10.4274/gulhane.galenos.2021.81300
Goyal, N., Agrawal, M., Dewani, D., Eleti, M.R. and Agrawal, M.S., 2023. A comparative study of the effectiveness of Transdermal Nitroglycerine patches and oral nifedipine in prolongation of pregnancy in Women with Preterm Labour. Cureus, 15(5). https://doi.org/10.7759/cureus.39106
El-Sayed, M.A., Abdelgaied, A.M., Fathey, A.A. and El-Shemy, E.M., 2021. Nifedipine versus Nifedipine and Progesterone Therapy in Acute Tocolysis in Preterm Labor and Their Effect on Maternal and Fetal blood flow. The Egyptian Journal of Hospital Medicine, 82(4), pp.668-674. https://doi.org/10.21608/ejhm.2021.150440
Gholami, L., Zare, H., Afroughi, S. and Eslamnik, P., 2023. Comparing the Effect of Nifedipine and Indomethacin on Pregnant Women with Idiopathic Preterm Labor. Journal of Clinical Care and Skills, 4(2), pp.91-96.
Singh, S.H.S.S., 2023. Effect of oral nifedipine or combined with sildenafil citrate for management of threatened preterm labour randomized trial. Indian Journal of Obstetrics and Gynecology Research, 10(3), pp.313-9.
https://doi.org/10.18231/j.ijogr.2023.063
Mohamed, M.O. and Wafa, Y., 2022. Comparison of the Efficacy of vaginal Progesterone and Nifidipine in inhibiting Threatened preterm labour: A randomized controlled study. Al-Azhar International Medical Journal, 3(6), pp.104-109. https://doi.org/10.21608/aimj.2022.112503.1747
Olda, A.J., Trixie, J.A., Bolang, G., Witular, Y.R. and Langi, S., 2022. Nifedipine, calcium channel blocker (antihypertensive), as a tocolytic to inhibit premature birth in reducing the risk of neonatal death in childbirth: meta-analysis and systematic review of large clinical trial. Indonesian Journal of Obstetrics and Gynecology, pp.58-62.
https://doi.org/10.32771/inajog.v10i1.1549
Lorthe, E. and Kayem, G., 2021. Tocolysis in the management of preterm prelabor rupture of membranes at 22–33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM). BMC pregnancy and childbirth, 21, pp.1-13.
https://doi.org/10.1186/s12884-021-04047-2
Alloush, M.K., Ebrahem, A.S., Mahmoud, M.A. and Abdelzaher, Y.M., 2021. Effectiveness of Nifedipine Compared to Vaginal Progesterone in Treatment of Threatened Preterm Birth. Benha Journal of Applied Sciences, 6(6), pp.161-168. https://doi.org/10.21608/bjas.2021.214406
Kaur, P., Madan, A. and Sharma, S., 2021. A comparative study of transdermal nitroglycerine patch and oral nifedipine in preterm labor. Annals of African Medicine, 20(1), pp.31-36.
https://doi.org/10.4103/aam.aam_11_20
Abd El-Aziz, R.H., Aboelwan, Y., Abdel-Salam, W.A. and Hamed, B.M., 2023. Comparative study between nifedipine alone versus nifedipine combined with sildenafil citrate for cases with threatened preterm labour. Zagazig University Medical Journal, 29(1.1), pp.1-8.
https://doi.org/10.21608/zumj.2020.38771.1918
Hafeez, S., Khan, B., Khan, M., Syed, S.Z., Waheed, F. and Mustafa, R., 2023. Is Vaginal Progesterone More Effective to Treat Threatened Preterm Labour than Oral Nifedipine?. Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University, 19(4), pp.441-445.
https://doi.org/10.48036/apims.v13i4.977
Hemmati, Z., Hashemi, N., Gharooni, M., Soleimani, Z., Rokhgireh, S., Derakhshan, R. and Derakhshan, P., 2024. Comparison of the Effect of Oral Dydrogesterone with Oral Nifedipine on the Treatment of Threatened Preterm Labor: A Randomized Controlled Trial. Fertility, Gynecology and Andrology, 4(1).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
